BEAM Price Prediction Next Week
Analysis and Insights
News Sentiment and Recent Developments:
Beam Therapeutics (BEAM) has seen increased interest, with a 131% surge in search activity, indicating heightened investor attention. Additionally, Ark Invest purchased 28,717 shares of BEAM, showing institutional confidence. The stock recently closed at $24.01, with a 1.76% pre-market gain, suggesting positive momentum.
Technical Indicators:
- RSI (14): 43.25, indicating the stock is not oversold.
- MACD: Slightly negative, suggesting mild bearish momentum.
- Bollinger Bands: Trading near the lower band, indicating potential undervaluation.
Price Prediction and Recommendation:
Based on positive sentiment and technical indicators, BEAM is expected to rise to $25.50 next week. However, due to moderate technical signals, a cautious approach is advised. Consider holding or selling if resistance near $26 is reached.
BEAM Similar Chart Price Prediction
The price of BEAM is predicted to go up 1.61%, based on the high correlation periods with SBLK. The similarity of these two price pattern on the periods is 97.75%.
BEAM
SBLK
Up: 1.61%Similarity: 97.75%
BEAM Revenue Forecast
BEAM EPS Forecast
BEAM FAQs
What is BEAM revenue forecast for next quarter？
What is BEAM eps forecast for next quarter？
BEAM Analyst's Forecast
Greg Harrison
Scotiabank
Hold → Buy
2025-03-10
Price Target
$40
Upside
+55.7%
Scotiabank raised the firm's price target on Beam Therapeutics to $25 from $24 and keeps a Sector Perform rating on the shares. The firm likes the company's setup for the rest of the year, but remains cautious until more clinical derisking occurs, the analyst tells investors.
Soumit Roy
Jones Trading
Hold → Strong Buy
2025-03-10
Price Target
$34
Upside
+32.35%
Greg Harrison
Scotiabank
Hold
2025-03-03
Price Target
$24 → $25
Upside
+0.73%
